Joseph E. Bavaria | |
---|---|
Born | 1957 (age 66–67) |
Education | Tulane University, Tulane University School of Medicine |
Occupation(s) | Surgeon, academic |
Years active | 1983-present |
Medical career | |
Awards | The Society of Thoracic Surgeons’ (STS) 2022 Distinguished Service Award [1] |
Awards | Penn Health System Innovation Prize |
Academic work | |
Discipline | Surgery |
Sub-discipline | Cardiothoracic surgery |
Institutions | The University of Pennsylvania (Professor of Surgery), European Association for Cardio-Thoracic Surgery (International Councilor), Penn Cardiovascular Surgery (Roberts-Measey Professor and Vice-Chair), Penn Aorta Center (Founder and co-director) [2] |
Main interests | cardio-aortic surgery, thoracic aortic surgery, aortic dissection, aortic root, ascending aortic reconstruction, aortic arch surgery, [3] lung transplant, lung cancer, thoracoscopy, pleurodesis, aortic disease, aortic dissections, cerebral protection, aortic valve repairs, [4] and valve-sparing procedures [5] |
Website | josephbavaria |
Joseph E. Bavaria, M.D., FACS, FRCS (Edin) ad hom, (born 1957) is an American cardiothoracic surgeon [6] a professor of surgery at the University of Pennsylvania and Director of its Thoracic Aortic Surgery Program. [lower-alpha 2] [3] Bavaria is known as a leading figure in clinical trials for catheter-based aortic valve replacement (TAVR), thoracic aortic surgery, and aortic endograft procedures (TEVAR). [7] He wrote more than 600 research papers and founded the Penn Aortic Center. Bavaria served as the 52nd president of the Society of Thoracic Surgeons (STS) from 2016 to 2017, the 3rd President of the Thoracic Surgery Foundation (TSF) (2019-2022), the Chairman of The Society of Thoracic Surgeons/ACC TVT Registry Steering Committee (2017-2020) [lower-alpha 3] and an International Councilor of the European Association for Cardio-Thoracic Surgery (EACTS) (2021-2024) [9] [10] [5] Bavaria has performed more than 9,000 surgeries throughout his career as of 2019. [11] [12] [13]
Bavaria was born in 1957 to Elizabeth "Janee" Swank and Edward Bavaria in Little Rock, Arkansas. His father worked as a pilot for the United States Airforce until he started working for General Electric in 1962. Bavaria attended a Cincinnati kindergarten school until third grade. Then, his family moved first to Dallas, Texas and then to Bonn, Germany where they lived from 1967 to 1970. In Germany, his father worked with the embassy thanks to a public-private partnership between General Electric and the German Airforce. Bavaria attended the American School on the Rhine. In 1970, his father was promoted to Head of Engine Division in Europe at General Electric and the family moved to Paris before returning to Cincinnati four years later in 1974. Bavaria graduated from the Indian Hill High School. [lower-alpha 4] He attended Tulane University as an underdraguate and spent a year as an honors exchange student in Edinburgh, Scotland. He graduated with honors from Tulane University in 1979 with a degree in chemical engineering and then attended Tulane University School of Medicine. During his years at Tulane's Medical School, he had an externship in cardiac and thoracic surgery in Cincinnati where he decided to pursue a career in cardiothoracic surgery. He graduated from Tulane's Medical School and was awarded the "Gold Scalpel Award", the highest surgery honor for a medical student. In July 1983, he started his residency as a surgeon at the Hospital of the University of Pennsylvania (HUP). [5] [14]
Bavaria finished his residency at HUP in 1992 and started working as an assistant professor of Thoracic and Cardiovascular Surgery at The University of Pennsylvania until 2004 when he was awarded the Brooke Roberts–William Maul Measey Professorship of Surgery. [14]
During his years teaching at Penn, Bavaria has written more than 600 research paper [5] and was an associate editor at The Annals of Thoracic Surgery. [3]
Bavaria holds the role of Primary Investigator at Penn, [15] overseeing the continuous transcatheter aortic valve trials. He plays a prominent role in a dynamic cardio-aortic clinical research group, serving as the main investigator for more than 40 industry-sponsored FDA IDE phase I, II, and III trials. He is also actively involved in ongoing NIH-funded research projects. [5]
During the second year of his surgical residency at the Hospital of the University of Pennsylvania, Bavaria had met Kimberly Franco, a school psychologist. They married four years later. Bavaria and Franco have two children, Melanie and Edward. [5] [16]
Aortic stenosis is the narrowing of the exit of the left ventricle of the heart, such that problems result. It may occur at the aortic valve as well as above and below this level. It typically gets worse over time. Symptoms often come on gradually with a decreased ability to exercise often occurring first. If heart failure, loss of consciousness, or heart related chest pain occur due to AS the outcomes are worse. Loss of consciousness typically occurs with standing or exercising. Signs of heart failure include shortness of breath especially when lying down, at night, or with exercise, and swelling of the legs. Thickening of the valve without causing obstruction is known as aortic sclerosis.
Vascular surgery is a surgical subspecialty in which vascular diseases involving the arteries, veins, or lymphatic vessels, are managed by medical therapy, minimally-invasive catheter procedures and surgical reconstruction. The specialty evolved from general and cardiovascular surgery where it refined the management of just the vessels, no longer treating the heart or other organs. Modern vascular surgery includes open surgery techniques, endovascular techniques and medical management of vascular diseases - unlike the parent specialities. The vascular surgeon is trained in the diagnosis and management of diseases affecting all parts of the vascular system excluding the coronaries and intracranial vasculature. Vascular surgeons also are called to assist other physicians to carry out surgery near vessels, or to salvage vascular injuries that include hemorrhage control, dissection, occlusion or simply for safe exposure of vascular structures.
A thoracic aortic aneurysm is an aortic aneurysm that presents primarily in the thorax.
Aortic valve replacement is a procedure whereby the failing aortic valve of a patient's heart is replaced with an artificial heart valve. The aortic valve may need to be replaced because:
Transcatheter aortic valve implantation (TAVI) is the implantation of the aortic valve of the heart through the blood vessels without actual removal of the native valve. The first TAVI was performed on 16 April 2002 by Alain Cribier, which became a new alternative in the management of high-risk patients with severe aortic stenosis. The implantated valve is delivered via one of several access methods: transfemoral, transapical, subclavian, direct aortic, and transcaval, among others.
Mitral valve replacement is a procedure whereby the diseased mitral valve of a patient's heart is replaced by either a mechanical or tissue (bioprosthetic) valve.
Endovascular aneurysm repair (EVAR) is a type of minimally-invasive endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). When used to treat thoracic aortic disease, the procedure is then specifically termed TEVAR for "thoracic endovascular aortic/aneurysm repair." EVAR involves the placement of an expandable stent graft within the aorta to treat aortic disease without operating directly on the aorta. In 2003, EVAR surpassed open aortic surgery as the most common technique for repair of AAA, and in 2010, EVAR accounted for 78% of all intact AAA repair in the United States.
David H. Adams is an American cardiac surgeon and the Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai Hospital in New York City. Dr. Adams is a recognized leader in the field of heart valve surgery and mitral valve reconstruction. As director of Mount Sinai Mitral Valve Repair Center, he has set national benchmarks with >99% degenerative mitral valve repair rates, while running one of the largest valve repair programs in the United States. Dr. Adams is the co-inventor of 2 mitral valve annuloplasty repair rings – the Carpentier-McCarthy-Adams IMR ETlogix Ring and the Carpentier-Edwards Physio II Annuloplasty Ring, and is a senior consultant with royalty agreements with Edwards Lifesciences. He is also the inventor of the Tri-Ad Adams Tricuspid Annuloplasty ring with a royalty agreement with Medtronic. He is a co-author with Professor Alain Carpentier of the benchmark textbook in mitral valve surgery Carpentier's Reconstructive Valve Surgery. He is also the National Co-Principal Investigator of the FDA pivotal trial of the Medtronic-CoreValve transcatheter aortic valve replacement device.
Randall Bertram Griepp was an American cardiothoracic surgeon who collaborated with Norman Shumway in the development of the first successful heart transplant procedures in the U.S. He had an international reputation for contributions to the surgical treatment of aortic aneurysms and aortic dissection and in heart and lung transplantations. He received nearly $8 million in grants from the National Heart, Lung, and Blood Institute.
Robert E. Michler is an American heart surgeon specializing in heart surgery, aortic and mitral valve repair, coronary artery bypass surgery, aneurysm surgery, and management of the failing heart. In 2017, Michler received the Vladimir Borakovsky Prize in Moscow from the Ministry of Health of the Russian Federation for “his personal contributions to the development of cardiovascular surgery”.
Lars Georg Svensson is a cardiac surgeon and the chairman of the heart and vascular institute at Cleveland Clinic. He is the Director of the Aorta Center, Director of the Marfan Syndrome and Connective Tissue Disorder Clinic, and is a professor of surgery at Cleveland Clinic Lerner College of Medicine and Case Western Reserve University. He is also the Director of Quality Outcomes and Process Improvement for the Department of Thoracic and Cardiovascular Surgery and Affiliate Cardiac Surgery Program at Cleveland Clinic.
A hybrid cardiac surgical procedure in a narrow sense is defined as a procedure that combines a conventional, more invasive surgical part with an interventional part, using some sort of catheter-based procedure guided by fluoroscopy imaging in a hybrid operating room (OR) without interruption. The hybrid technique has a reduced risk of surgical complications and has shown decreased recovery time. It can be used to treat numerous heart diseases and conditions and with the increasing complexity of each case, the hybrid surgical technique is becoming more common.
The Society of Thoracic Surgeons is a Chicago, Illinois (US)-based medical specialty professional society in the field of cardiothoracic surgery. Membership worldwide includes more than 7,500 surgeons, researchers, and other health care professionals who are part of the cardiothoracic surgery team. The Society's official journal is The Annals of Thoracic Surgery.
Open aortic surgery (OAS), also known as open aortic repair (OAR), describes a technique whereby an abdominal, thoracic or retroperitoneal surgical incision is used to visualize and control the aorta for purposes of treatment, usually by the replacement of the affected segment with a prosthetic graft. OAS is used to treat aneurysms of the abdominal and thoracic aorta, aortic dissection, acute aortic syndrome, and aortic ruptures. Aortobifemoral bypass is also used to treat atherosclerotic disease of the abdominal aorta below the level of the renal arteries. In 2003, OAS was surpassed by endovascular aneurysm repair (EVAR) as the most common technique for repairing abdominal aortic aneurysms in the United States.
Decellularized homografts are donated human heart valves which have been modified via tissue engineering. Several techniques exist for decellularization with the majority based on detergent or enzymatic protocols which aim to eliminate all donor cells while preserving the mechanical properties of the remaining matrix.
Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.
Marjan Jahangiri FRCS, FRCS (CTh) is Professor of Cardiac Surgery at St. George's Hospital, University of London. She was the first woman to be appointed professor of cardiac surgery in the United Kingdom and Europe.
Hazim J. Safi, MD, FACS, is a physician and surgeon who is well known for his research in the surgical treatment of aortic disease. Safi and his colleagues at Baylor College of Medicine were the first to identify variables associated with early death and postoperative complications in patients undergoing thoracoabdominal aortic operations. Safi now serves as professor of cardiothoracic surgery, and founding chair at McGovern Medical School at The University of Texas Health Science Center in Houston, TX.
John D. Puskas is an American researcher, author, inventor and cardiovascular surgeon. As of 2022, he is Professor, Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, and chairman, Department of Cardiovascular Surgery at Mount Sinai Morningside, Mount Sinai Beth Israel and Mount Sinai West. He holds 11 U.S. patents and co-founded the International Coronary Congress and the International Society for Coronary Artery Surgery. He is credited by ResearchGate with 330 publications and 15,234 citations and as of 2022 Scopus reports an h-index of 62. Puskas is known for advancing coronary artery bypass (CABG) surgery by refining surgical techniques for all-arterial, off-pump CABG and inventing finer instruments to be used for advanced coronary bypass surgical procedures. He is credited with performing the first totally thoracoscopic bilateral pulmonary vein isolation procedure. He is the co-editor of State of the Art Surgical Coronary Revascularization, the first textbook solely devoted to coronary artery surgery.
Joseph Lamelas is a Cuban-American cardiothoracic surgeon, working in Miami, Florida, who developed the "Miami method", a technique for minimally invasive approach to aortic valve replacement and repair. Lamelas is the Chief of Cardiac surgery and Professor of Surgery at the University of Miami Leonard M. Miller School of Medicine. He is board certified in general surgery, cardiac surgery and thoracic surgery, and surgical critical care, and is a member of the American Association for Thoracic Surgery (AATS) and the Society of Thoracic Surgeons (STS).